Viewing Study NCT05968768


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-25 @ 3:14 PM
Study NCT ID: NCT05968768
Status: RECRUITING
Last Update Posted: 2025-04-10
First Post: 2023-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Sponsor: Anna Raciborska
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module